Literature DB >> 7794310

Severe adverse cutaneous reactions to drugs.

J C Roujeau1, R S Stern.   

Abstract

Mesh：

Year:  1994        PMID： 7794310     DOI： 10.1056/NEJM199411103311906

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  246 in total

1.  Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.

Authors:  L Naldi; A Conforti; M Venegoni; M G Troncon; A Caputi; E Ghiotto; A Cocci; U Moretti; G Velo; R Leone
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Cutaneous manifestations of infectious diseases: approach to the patient with fever and rash.

Authors:  C V Sanders; F A Lopez
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

3.  Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.

Authors:  Kow-Tong Chen; Shiing-Jer Twu; Hong-Jen Chang; Ruey-Shiung Lin
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

4.  Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome.

Authors:  J Ahluwalia; K Abuabara; M J Perman; A C Yan
Journal:  Br J Dermatol       Date:  2015-02-27       Impact factor: 9.302

Review 5.  Reactive metabolites and adverse drug reactions: clinical considerations.

Authors:  Sandra R Knowles; Lori E Shapiro; Neil H Shear
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

6.  Teicoplanin induced drug hypersensitivity syndrome.

Authors:  C M Perrett; S R McBride
Journal:  BMJ       Date:  2004-05-29

7.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

Review 8.  [Severe cutaneous adverse drug reactions. Clinical features and epidemiology ].

Authors:  M Mockenhaupt
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

9.  Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.

Authors:  Christos S Zipitis; Nandu Thalange
Journal:  Eur J Pediatr       Date:  2006-09-29       Impact factor: 3.183

10.  HLA-B*59:01: a marker for Stevens-Johnson syndrome/toxic epidermal necrolysis caused by methazolamide in Han Chinese.

Authors:  F Yang; J Xuan; J Chen; H Zhong; H Luo; P Zhou; X Sun; L He; S Chen; Z Cao; X Luo; Q Xing
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.